MedPath
HSA Product

Zyr-NEX TABLET 5 mg

Product approved by Health Sciences Authority (SG)

Basic Information

Zyr-NEX TABLET 5 mg

TABLET, FILM COATED

Regulatory Information

SIN12084P

September 25, 2002

Pharmacy Only

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XR06AE09

Company Information

UCB FARCHIM S A

GLAXOSMITHKLINE PTE LTD

GLAXOSMITHKLINE PTE LTD

Active Ingredients

LEVOCETIRIZINE 2HCl

Strength: 5 mg

Detailed Information

Contraindications

**2\. Before you take Zyr-NEX** **Don't take Zyr-NEX** - if you are **allergic** ( _hypersensitive_) to levocetirizine, cetirizine, hydroxyzine, any piperazine derivatives (closely related active substances of other medicines) or any other ingredients of Zyr-NEX (listed in Section 6 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_) - if you have **severe kidney disease** (severe impairment of kidney function with creatinine clearance below 10 ml/min) - if you use other antiallergic medicines ➔If you think any of these apply to you, **don't take** Zyr-NEX until you have checked with your doctor.

Indication Information

**1\. What Zyr-NEX is and what it is used for** The active substance in Zyr-NEX is levocetirizine. Levocetirizine belongs to a group of antiallergic medicines called antihistamines. Zyr-NEX is used to treat symptoms such as sneezing, a runny nose and watery eyes associated with allergic rhinitis (including persistent allergic rhinitis). Zyr-NEX is also used to relieve the rashes and itching of chronic urticaria ( _hives_).

© Copyright 2025. All Rights Reserved by MedPath